Abstract
The precise pathogenesis of multiple sclerosis is unknown. The assumption of a primary immunopathogenesis of the disease is seriously flawed and has failed to deliver an effective therapy for most patients. The progressive degeneration of grey and white matter is integral to the natural history of the disease and is reflected in the atrophy of brain and spinal cord. Demyelination is an essential component of this primary neurodegenerative process rather than the target of a systemic immune response. The primary pathology of multiple sclerosis is a process of neurodegeneration based on the integrity of the blood–brain barrier. Primary progressive multiple sclerosis is the prototype neurodegenerative disease, and the relapsing-remitting form in younger population represents the modifying effect of steroids (vitamin D, sex and stress hormones) on metabolic functions of the central nervous system.
Similar content being viewed by others
References
Barcellos LF, Kamdar BB, Ramsay RP et al (2006) Clustering of an autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 5:924–931
Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458–468
Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DAS (2000) Autoimmune disease in the first-degree relatives of patients with multiple sclerosis: a UK survey. Brain 123:1102–1111
Chaudhuri A, Behan PO (2004) Multiple sclerosis is not an autoimmune disease. Arch Neurol 61:1610–1612
Etemadifar M, Abtahi SH, Akbari M et al (2012) Multiple sclerosis and amyotrophic lateral sclerosis: is there a link? Mult Scler 18:902–904
Ismail A, Cooper-Knock J, Highley JR et al (2013) Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. J Neurol Neurosurg Psychiatry 84:79–87
Landtblom AM, Riise T, Boiko A, Soderfeldt B (2002) Distribution of multiple sclerosis in Sweden based on mortality and disability compensation statistics. Neuroepidemiology 21:167–179
Rodriguez M, Scheithauer B (1994) Ultrastructure of multiple sclerosis. Ultrastruct Pathol 18:3–13
Shirani A, Zhao Y, Karim ME et al (2012) Association between use of interferon beta and progression of disability in patients with relapsing remitting multiple sclerosis. JAMA 308:247–256
Trapp BD, Nave K-A (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247–269
van Doormaal PTC, Gallo A, van Rheenen W et al (2013) Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2012-304864
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chaudhuri, A. Multiple sclerosis is primarily a neurodegenerative disease. J Neural Transm 120, 1463–1466 (2013). https://doi.org/10.1007/s00702-013-1080-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-013-1080-3